Copyright
©The Author(s) 2023.
World J Cardiol. Sep 26, 2023; 15(9): 427-438
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
Published online Sep 26, 2023. doi: 10.4330/wjc.v15.i9.427
B | SE | Wald | df | Sig | Exp (B) | 95%CI for Exp (B) | ||
Lower | Upper | |||||||
Age | 0.022 | 0.004 | 26.460 | 1 | 0.000 | 1.022 | 1.014 | 1.031 |
Ventilator use | -0.378 | 0.157 | 5.830 | 1 | 0.016 | 0.685 | 0.504 | 0.931 |
Intensive care unit admission | 1.624 | 0.164 | 97.657 | 1 | 0.000 | 5.074 | 3.677 | 7.003 |
Troponin | 0.219 | 0.133 | 2.705 | 1 | 0.100 | 1.245 | 0.959 | 1.616 |
- Citation: Umeh CA, Maoz H, Obi J, Dakoria R, Patel S, Maity G, Barve P. Remdesivir, dexamethasone and angiotensin-converting enzyme inhibitors use and mortality outcomes in COVID-19 patients with concomitant troponin elevation. World J Cardiol 2023; 15(9): 427-438
- URL: https://www.wjgnet.com/1949-8462/full/v15/i9/427.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i9.427